New hope for Mild Cognitive Impairment available now

BrainXpert, from Nestlé Health Science, is the first effective nutritional intervention for people diagnosed with Mild Cognitive Impairment (MCI), signaling a major breakthrough for the MCI community that, until now, has had no available treatments

• MCI affects 15-20% of people aged 65+, yet more than half of British people (58%) know nothing or little about the common condition
• BrainXpert can help improve brain function and reduce symptoms of MCI including memory loss and forgetfulness

New hope has been offered today to people diagnosed with Mild Cognitive Impairment (MCI), as the first nutritional intervention for the condition affecting 15-20% of people aged 65+¹ becomes available.

BrainXpert, a groundbreaking new specialized ketogenic drink, from Nestlé Health Science, has been clinically proven² to support brain function in people with MCI, and reduce the symptoms of the condition, including memory loss, forgetfulness, and a decline in decision-making ability and judgment.

According to new research³ released today by Nestlé Health Science to support the launch of BrainXpert, more than half of British people (58%) know nothing, or little, about MCI despite the condition being twice as prevalent as dementia⁴. In fact, only 3% of people surveyed, aged 55+, said they were likely to go to the doctor if they were worried about or experiencing symptoms of MCI – despite this age group being at the highest risk of developing the condition. ⁵

More than a quarter (28%) of British people consider symptoms of MCI, including memory loss and forgetfulness, a ”normal” part of aging.

“It’s not uncommon for people to shrug off symptoms of cognitive decline as simply signs of ‘getting older,’ but if you are becoming increasingly forgetful or feel that you are not thinking as clearly as you used to, you should speak to a healthcare professional,” said Hans-Juergen Woerle, Chief Medical and Scientific Officer for Nestlé Health Science. “Symptoms of Mild Cognitive Impairment should be taken seriously. Nestlé Health Science’s research into MCI and its development of a clinically proven nutritional intervention to help improve brain function in people with MCI is a game-changer. It’s part of our ongoing commitment to using the science of nutrition to develop products that can help people live healthier lives.”

MCI is a decline in cognitive functioning⁶ considered a transitional stage between normal ageing and dementia⁷. In part, MCI develops when a person’s brain has less glucose available as a source of energy⁸, resulting in symptoms including memory loss, forgetfulness, and a decline in decision-making ability and judgment.

The BENEFIC clinical trial confirmed BrainXpert Energy Complex (a compound within BrainXpert) as an effective, alternative brain energy source for people living with MCI, with trial participants showing improved memory and word recall, and increased ability to think quicker and multitask when taking BrainXpert Energy Complex, twice a day for six months.

Clinical trial principal investigator, Professor Stephen Cunnane, from the University of Sherbrooke, said, “Identifying significant improvement in cognitive function in patients with MCI is an exciting development that gives us great motivation to stay on this research track. This is only the beginning and the hope is that new innovations can be found to not just boost brain function, but to slow down progression to Alzheimer’s disease and other forms of cognitive decline linked to ageing. These results should significantly improve the quality of life for people living with Mild Cognitive Impairment.” Up to 50% of people diagnosed with MCI develop Alzheimer’s disease after 5 years.⁹